1. Home
  2. THW vs LXRX Comparison

THW vs LXRX Comparison

Compare THW & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

THW

abrdn World Healthcare Fund Shares of Beneficial Interest

N/A

Current Price

$12.20

Market Cap

513.9M

Sector

Finance

ML Signal

N/A

LXRX

Lexicon Pharmaceuticals Inc.

N/A

Current Price

$1.63

Market Cap

547.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
THW
LXRX
Founded
N/A
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
513.9M
547.4M
IPO Year
2015
2000

Fundamental Metrics

Financial Performance
Metric
THW
LXRX
Price
$12.20
$1.63
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.63
AVG Volume (30 Days)
142.6K
2.2M
Earning Date
01-01-0001
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.78
EPS
N/A
N/A
Revenue
N/A
$49,803,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$22.16
P/E Ratio
N/A
N/A
Revenue Growth
N/A
60.24
52 Week Low
$9.80
$0.32
52 Week High
$13.19
$1.83

Technical Indicators

Market Signals
Indicator
THW
LXRX
Relative Strength Index (RSI) 39.02 60.31
Support Level $11.80 $1.08
Resistance Level $13.00 $1.65
Average True Range (ATR) 0.20 0.13
MACD -0.06 0.02
Stochastic Oscillator 27.50 58.44

Price Performance

Historical Comparison
THW
LXRX

About THW abrdn World Healthcare Fund Shares of Beneficial Interest

Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: